Policy Concerning Development

The compounds which have had their efficacy and safety confirmed through research are evaluated in clinical trials. Through this process we demonstrate how their efficacy, as well as safety, is effective for people playing an important role to pave the way for applications and obtaining approval. There are many intractable diseases of which causes have yet to be unraveled and many patients worldwide who await superior pharmaceutical products. A key part of Takeda's mission is providing quality drugs for patients as quickly as possible. Potential new chemical compounds must be strictly checked as well as having their efficiency and safety scrutinized from a scientific perspective. Takeda implements intensive quality control, including compliance checking programs, and conducts clinical trials working in proximity with external experts such as physicians and toxicity professionals to achieve pharmaceutical products capable of satisfying user needs. In an effort to secure drug quality and accelerate the launch of pharmaceutical products, Takeda is working to strengthen its product development activities on a global basis by developing a system to share clinical data among tripolar operation bases in Japan, the United States and Europe as well as preparing effective and flexible plans for clinical trials.